Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate

被引:26
|
作者
Amital, H
Applbaum, YH
Vasiliev, L
Rubinow, A
机构
[1] Hadassah Hebrew Univ Sch Med, Dept Radiol, Rheumatol Unit, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ Sch Med, Div Internal Med, IL-91120 Jerusalem, Israel
关键词
bisphosphonates; cyanotic heart disease; hypertrophic pulmonary osteoarthropathy; pain; pamidronate;
D O I
10.1007/s10067-004-0941-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This case presents a patient with hypertrophic osteoarthropathy of the lower extremities that developed secondary to congenital cyanotic heart disease. The major clinical manifestation was severe bilateral leg pain. The pain that was debilitating in nature completely resolved following a single administration of 60 mg pamidronate. Hypertrophic osteoarthropathy (HOA) is an acquired, uncommon disorder of obscure etiology. It has been described mainly in association with chronic suppurative pulmonary diseases, bronchogenic carcinoma and lung metastases, cystic fibrosis, and cyanotic congenital malformations of the heart.
引用
收藏
页码:330 / 332
页数:3
相关论文
共 50 条
  • [21] PULMONARY HYPERTROPHIC OSTEOARTHROPATHY
    HOLLING, HE
    BOLAND, HC
    BRODEY, RS
    LANCET, 1961, 2 (721): : 1269 - &
  • [22] HYPERTROPHIC OSTEOARTHROPATHY AFTER KIDNEY TRANSPLANTATION TREATED WITH PAMIDRONATE
    See, Sein Yin
    Fillaus, Jennifer
    Ericson, Erik
    Stevens, Brian
    Rao, Vinaya
    Miles, Clifford
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A69 - A69
  • [23] Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide
    Johnson, SA
    Spiller, PA
    Faull, CM
    THORAX, 1997, 52 (03) : 298 - 299
  • [24] Pain Management in Hypertrophic Pulmonary Osteoarthropathy: An Illustrative Case and Review
    Kilaru, Malathy
    Vitale, Caroline
    Montagnini, Marcos
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2012, 29 (04): : 302 - 307
  • [25] Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma
    Suzuma, T
    Sakurai, T
    Yoshimura, G
    Umemura, T
    Tamaki, T
    Yoshimasu, T
    Naito, Y
    ANTI-CANCER DRUGS, 2001, 12 (09) : 731 - 734
  • [26] HYPERTROPHIC PULMONARY OSTEOARTHROPATHY IN PULMONARY METASTASES
    FIROOZNIA, H
    SELIGER, G
    GENIESER, NB
    BARASCH, E
    RADIOLOGY, 1975, 115 (02) : 269 - 274
  • [27] Hypertrophic pulmonary osteoarthropathy without
    Clarke, S
    Barnsley, L
    Peters, M
    Morgan, L
    Van der Wall, H
    SKELETAL RADIOLOGY, 2001, 30 (11) : 652 - 655
  • [28] PULMONARY HYPERTROPHIC OSTEOARTHROPATHY - REPLY
    HOLLING, HE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 180 (01): : 88 - &
  • [29] Information on hypertrophic pulmonary osteoarthropathy
    Kruger
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1906, 185 (01): : 43 - 52
  • [30] HYPERTROPHIC PULMONARY OSTEOARTHROPATHY IN A COW
    MARTIN, SW
    PENNOCK, PW
    PASS, D
    CANADIAN VETERINARY JOURNAL, 1971, 12 (06): : 129 - &